Argireline vs Matrixyl
Argireline (Cosmetic signal peptide) and Matrixyl (Cosmetic signal peptide) are documented as co-studied in the PeptiDex library. This page puts the two entries side by side on class, molecular weight, half-life, origin, mechanism and studied research areas — every value taken from the entry it belongs to.
Why these two are co-studied
Cross-referenced for research context — not a usage or combination recommendation.
At a glance
| Attribute | Argireline | Matrixyl |
|---|---|---|
| Compound class | Cosmetic signal peptide | Cosmetic signal peptide |
| Research category | Cosmetic & Dermal | Cosmetic & Dermal |
| Length (amino acids) | 6 amino acids | 5 amino acids |
| Molecular weight | ~889 g/mol | ~802 Da |
| Half-life | Not documented | Not documented |
| Origin | Argireline is a trade name for acetyl hexapeptide-8 (also called acetyl hexapeptide-3), a synthetic cosmetic peptide developed by Lipotec for topical anti-wrinkle use. It is designed to mimic the N-terminal end of the SNAP-25 protein. | Matrixyl is a trade name for palmitoyl pentapeptide-4 (INCI; formerly palmitoyl pentapeptide-3), a lipidated matrikine peptide developed by Sederma for topical anti-aging cosmetics. Related products include Matrixyl 3000 and Matrixyl synthe'6, which use different peptide combinations. |
“Not documented” means the PeptiDex entry records no value for that field. Nothing on this page is estimated, and no figure is carried over from one compound to the other.
How Argireline works
Argireline is a topical hexapeptide modeled on the N-terminus of SNAP-25, a component of the SNARE complex that mediates vesicle docking and neurotransmitter release. By competing with SNAP-25 in SNARE complex assembly in its proposed mechanism, it is intended to attenuate signaling that drives facial-muscle contraction, thereby softening the appearance of expression lines. It is often described as a topical, cosmetic-strength analog to the neuromuscular effect of botulinum toxin, though supporting data are largely cosmetic/supplier-derived.
How Matrixyl works
Matrixyl couples a matrikine pentapeptide (KTTKS, a fragment derived from type I collagen) to a palmitoyl group that improves skin penetration. The KTTKS motif is proposed to act as a signal fragment that stimulates fibroblasts to increase synthesis of extracellular matrix components such as collagen and glycosaminoglycans. This 'matrikine signaling' is the basis of its cosmetic use to improve skin firmness and reduce fine-line appearance.
Mechanistic descriptions reflect published research-literature understanding and are quoted from each compound's own entry. Much peptide research is preclinical (in-vitro or animal-model); mechanism in humans may differ and is not established for many compounds.
Where each one appears in the literature
The research contexts each entry documents. Listing a research area is not a claim of efficacy or a therapeutic indication, and the two lists are not scored against each other.
Argireline
Matrixyl
What sets each apart
Argireline
Argireline is the original SNAP-25-mimicking hexapeptide; SNAP-8 is its elongated analog, and both differ from collagen-signaling matrikines like Matrixyl.
Matrixyl
Matrixyl works via matrikine collagen-stimulation signaling rather than the neurotransmitter/SNARE modulation attributed to Argireline and SNAP-8.
Frequently asked questions
What is Argireline?
Argireline is the trade name for acetyl hexapeptide-8 (also historically called acetyl hexapeptide-3), a synthetic six-amino-acid topical cosmetic peptide. Its sequence, Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2, mimics the N-terminal end of the SNAP-25 protein.
How does Argireline work?
Argireline is proposed to interfere with the SNARE complex needed for neurotransmitter (acetylcholine) release, which in cosmetic framing is described as modestly reducing the facial-muscle contractions that form expression lines. It is sometimes described as a topical, far milder analogy to botulinum toxin's mechanism.
What topical concentration of Argireline is used?
Cosmetic formulations commonly use 5%-10% active peptide, with 10% being the most-referenced clinical-strength level. A frequently cited study reported up to ~30% reduction in wrinkle depth after 30 days of use at a 10% concentration.
How does Matrixyl differ from Argireline or SNAP-8?
Matrixyl is a collagen-stimulating (matrix-signaling) peptide, whereas Argireline and SNAP-8 are neuro-signaling peptides that target expression-line muscle contraction. Because the mechanisms are complementary, they are often formulated together.
What is Matrixyl?
Matrixyl (palmitoyl pentapeptide-4, Pal-KTTKS) is a topical cosmetic lipopeptide consisting of the pentapeptide KTTKS (a fragment of type I procollagen) conjugated to a palmitic-acid chain that improves skin penetration. It is used as a collagen-signaling anti-aging ingredient.
How does Matrixyl work?
The KTTKS motif is a fragment released during collagen breakdown that acts as a feedback signal to fibroblasts. In cell-culture research, Pal-KTTKS has been reported to stimulate synthesis of collagen and extracellular-matrix components such as fibronectin, which underlies its use in skin-firming formulations.
Answers are the ones published on each compound's own PeptiDex entry. They are educational summaries of research-literature context and are not medical advice.